Source: BioPortfolio

ZappRx: CureDuchenne Invests in ZappRx Platform to Streamline Specialty Prescribing for Patients Suffering from Duchenne Muscular Dystrophy

Nonprofit invests in leading specialty prescription and prior authorization solution provider to get Duchenne patients breakthrough medications faster ZappRx Inc. a digital health company that streamlines specialty me...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Zoe Barry's photo - Founder & CEO of ZappRx

Founder & CEO

Zoe Barry

CEO Approval Rating

82/100

Read more